Cargando…
Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune Disease
BACKGROUND: Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder that predominantly affects women and is associated with prevalent hypertension, renal injury, and cardiovascular disease. Immune system dysfunction is recognized as an important factor in the pathogenesis of hypertension...
Autores principales: | Taylor, Erin B., Ryan, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524041/ https://www.ncbi.nlm.nih.gov/pubmed/28242635 http://dx.doi.org/10.1161/JAHA.116.005394 |
Ejemplares similares
-
Autoimmune Gastritis Treated With Mycophenolate Mofetil
por: Harb, Ali H., et al.
Publicado: (2020) -
Mycophenolate Mofetil Attenuates DOCA-Salt Hypertension: Effects on Vascular Tone
por: Moes, Arthur D., et al.
Publicado: (2018) -
Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
por: Park, Seung Woon, et al.
Publicado: (2016) -
Immunosuppression by Mycophenolate Mofetil Mitigates Intrarenal Angiotensinogen Augmentation in Angiotensin II-Dependent Hypertension
por: Satou, Ryousuke, et al.
Publicado: (2022) -
Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease
por: Jones, Rachel B., et al.
Publicado: (2014)